课题基金 / 基金详情

HETEROGENEITY AMONG HUMAN CD4+ T CELL CLONES

HETEROGENEITY AMONG HUMAN CD4+ T CELL CLONES
人类 CD4 T 细胞克隆的异质性
批准号:
6219299
负责人:
DALE T UMETSU
金额:
$0.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

DALE T UMETSU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goals of our research protocols are to determine the mechanisms that result in allergic asthma. Toward this end, we are determining the cellular and molecular mechanisms that control IL-4 expression in CD4+ T cells, and regulate the development of unresponsiveness in antigen specific T cells. These studies involve determining the role of antigen presenting cells such as alveolar macrophages from allergic and nonallergic individuals, as well as those with asthma in influencing cytokine production and tolerance induction in T cells. We will also determine how viral infection influences these processes. These studies will lead to a better understanding of the critical immunologic response that underlie allergy and tolerance induction. Such an understanding will be key in the design of novel immunotherapies for disease such as allergy and asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting innate lymphoid cells during influenza virus-induced asthma
  • 批准号:
    8566307
  • 项目类别:
  • 资助金额:
    $16.94万
  • 财政年份:
    2012
  • 负责人:
    DALE T UMETSU
  • 依托单位:
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
  • 批准号:
    8044035
  • 项目类别:
  • 资助金额:
    $18.83万
  • 财政年份:
    2010
  • 负责人:
    DALE T UMETSU
  • 依托单位:
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
  • 批准号:
    7877661
  • 项目类别:
  • 资助金额:
    $24.97万
  • 财政年份:
    2010
  • 负责人:
    DALE T UMETSU
  • 依托单位:
NKT cells recognize and respond to microbes at mucosal surfaces
  • 批准号:
    7706862
  • 项目类别:
  • 资助金额:
    $25.08万
  • 财政年份:
    2009
  • 负责人:
    DALE T UMETSU
  • 依托单位:
海外基金